Suntory Holdings is acquiring Daiichi Sankyo Healthcare, maker of Loxonin, Lulu, and Minon, for $1.55 billion. As Japan's youth abandon alcohol and the population ages rapidly, the beverage giant pivots to self-care. We analyze the deal, the booming OTC market, and what it means for global healthcare trends.
Researchers at Utsunomiya University have provided the world's first direct proof that ceramide deficiency in the skin causes atopic dermatitis. Using transgenic mice, they demonstrated the full disease cascade from barrier breakdown to allergic inflammation — opening doors for ceramide-based therapies and enzyme-targeting treatments for the 200+ million people affected worldwide.
Japan's government has approved a plan to make standard childbirth costs free by 2026. But the Japan Association of Obstetricians warns of a looming collapse in maternity care, delivery facilities have halved since 1996, and rural 'maternity deserts' are spreading. How does Japan's birth system compare to France and Sweden?
Japanese researchers cloned mice from a single donor for 20 years, producing over 1,200 animals across 58 generations. After the 27th generation, lethal mutations accumulated until all 58th-generation clones died within days of birth — the first proof that mammal cloning has a hard biological limit.
Japan's iCELL BANK launched in April 2026, offering individuals the ability to create and cryopreserve their own iPS cells for future regenerative medicine. Using ID Pharma's Sendai virus vector technology, the service marks a new phase in commercializing the Nobel Prize-winning iPS cell technology for everyday consumers.
Nobel laureate Shinya Yamanaka explained iPS Cell 2.0 on NTV's Bankisha. From next-gen stem cell tech overcoming current limitations to universal blood platelets that bypass blood-type matching, plus Japan's historic first-ever iPSC drug approvals in 2026 — a comprehensive look at where iPS cells stand 20 years after their discovery.
Fujitsu and Osaka University developed STAR Architecture ver. 3 and molecular model optimization to cut quantum computing resources to between 1/15 and 1/80 of conventional FTQC needs. Calculations for drug-critical Cytochrome P450 fall from 740,000 to 40,000 qubits and complete in 9 days. Comparison with IBM, Google, and IonQ's quantum drug discovery efforts included.
Omron announced it will sell its founding electronic components business — relays, sensors, and connectors dating back to 1933 — to U.S. private equity firm Carlyle Group at an enterprise value of ¥81 billion ($540M). A deep dive into Omron's strategic pivot to industrial automation and healthcare, and what this means for Japan's electronics industry restructuring.
Researchers at the University of Tokyo developed an AI model that integrates cine MRI imagery of uterine peristalsis with clinical data, significantly improving pregnancy prediction for patients with recurrent implantation failure. The novel approach condenses 18 seconds of uterine movement into a single image for deep learning analysis.
Not the iPS cells themselves, but the liquid they're grown in, injected into arthritic knees. A Japanese team's world-first study showed 71.4% improvement by international criteria with no serious adverse events. We look at what a seven-patient uncontrolled pilot can and cannot tell us, and where conditioned medium sits in Japan's regulations.
Japanese esports team ZETA DIVISION partners with the University of Tokyo to scientifically extend pro player careers through neuroscience research on reflexes, cognition, and motor control. Fighting game legends Momochi and Higuchi join the study.
Japanese startup Orizuru Therapeutics has begun clinical trials transplanting iPS cell-derived islet cells into diabetes patients. The first-ever transplant surgery succeeded in February 2025, with company-sponsored trials planned in Japan and the US. Over a decade after Professor Yamanaka's Nobel Prize, Japan's regenerative medicine enters the practical stage.
Shibaura Institute of Technology and AIST have measured the stable carbon isotope ratios of PFOA and PFOS, a world first for PFOS, using an Orbitrap that reads the chemical fingerprint without burning the sample. River spike tests proved it works on real environmental water, opening a path to identifying PFAS pollution sources. The bench work was a senior thesis. Japan made its 50 ng/L tap water standard legally binding in April 2026.
The Mirai Human Washing Machine, tried by 1,277 people at the 2025 Osaka Expo with 98.3% satisfaction, is now sold at Yamada Denki. The 60-million-yen ($370,000) flagship is limited to 40-50 hand-built units, alongside a 1.45-million-yen ($9,000) model aimed at care homes.
Japan's health ministry adds "Sleep Disorder" as a new medical specialty for the first time since 2008. With the shortest sleep duration among OECD nations and $100 billion in annual economic losses, Japan is officially confronting its sleep crisis.
On March 6, 2026, Japan's Health Minister formally approved ReHeart (severe heart failure) and Amshepri (Parkinson's disease), the world's first iPS cell-derived medical products. In May, Amshepri became the first iPS product covered by public insurance, priced at 55.3 million yen. Here are the conditions, the seven-year deadline, and the objections.
Researchers at the University of Tokyo have built the CUBIC Organ/Body Atlas, a 3D map of every cell across all organs of mice and the entire body of newborn mice at single-cell resolution. Combining the CUBIC tissue-clearing method with a custom light-sheet microscope, the team pinpointed roughly 610 million cells in a newborn mouse. Published in Cell, the work points toward 3D pathology and whole-body drug evaluation.
Japan's largest Kampo maker, Tsumura, will acquire the core business of Yomeishu Seizo, maker of the 400-year-old medicinal herbal liquor, for about $45 million. We break down the unusual multi-stage deal run through activist investor Yoshiaki Murakami's vehicles, and why Japanese traditional medicine is looking outward.
Osaka University spinoff Reimei has launched the world's first corporate clinical trial of a corneal epithelial cell sheet made from donor-derived iPS cells, with the first transplant performed on July 9, 2026. How the approach could ease the global corneal donor shortage, what the Lancet-published first-in-human data showed, and where Japan's regenerative medicine regulation stands against the US FDA.
An upside-down jellyfish and a starlet sea anemone, neither with a brain, each sleep about eight hours a day and nap. A January 2026 Nature Communications paper argues that what sleep is doing there is not resting a brain but repairing DNA damage in neurons.